Bank of Montreal, Canada: Maintaining the Bristol-Myers Squibb (BMY.US) rating, adjusted from a consistent market rating to a consistent market rating, and the target price was adjusted from $55.00 to $48.00.
加拿大蒙特利尔银行：维持Bristol-Myers Squibb(BMY.US)评级，由大市一致调整至大市一致评级, 目标价由55.00美元调整至48.00美元。
Bank of Montreal, Canada: Maintaining the Bristol-Myers Squibb (BMY.US) rating, adjusted from a consistent market rating to a consistent market rating, and the target price was adjusted from $55.00 to $48.00.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.